tiprankstipranks
Trending News
More News >

WuXi AppTec Schedules Board Meeting to Review Q1 2025 Results

Story Highlights
WuXi AppTec Schedules Board Meeting to Review Q1 2025 Results

WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has provided an update.

WuXi AppTec Co., Ltd. has announced that its Board of Directors will convene on April 28, 2025, to review and approve the company’s first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting stakeholders’ perceptions and the company’s market positioning.

More about WuXi AppTec Co., Ltd. Class H

WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical and biotechnology industry. The company, along with its subsidiaries, focuses on providing comprehensive research and development services to the pharmaceutical, biotechnology, and medical device industries.

YTD Price Performance: -9.20%

Average Trading Volume: 8,077,739

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$154.5B

For detailed information about 2359 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App